Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Transplant Cell Ther. 2022 Jul 11;28(10):657–666. doi: 10.1016/j.jtct.2022.07.008

Figure 1.

Figure 1.

Recommended practices for biomarker development. *Validation requires evaluation in at least 2 independent cohorts.$Once a candidate protein reaches the qualification phase,it is called a biomarker of a specific type (see definitions).